#596: Why Do Omega-3 Trials Show Mixed Results?

In clinical practice effective nutrition, exercise, and obesity care is rarely about identifying the single "best" plan on paper. Instead, sustainable change depends on behavioral psychology: understanding the person's context, motivation, barriers, and patterns, then co-designing practical steps that can actually be implemented in real life. David Creel PhD, RD is a clinical psychologist and registered dietitian working in weight management at the Cleveland Clinic. Dr. Creel discusses how clinicians can bridge the gap between "optimal recommendations" and what is most likely to create actual behaviour change. This includes a combination of using collaborative communication, self-monitoring, skill-building, relapse prevention planning, and a multidisciplinary framework. Behavioral and psychological factors shape food choices, physical activity, and adherence far more than knowing the newest guideline. In addition, the modern obesity treatment landscape (including GLP-1 receptor agonists) increases the need for structured behavior-change support: people may experience new hope and new fear (especially fear of weight regain), and the key clinical question becomes how to use these tools to build durable habits and reduce relapse risk over the long term. Timestamps [03:09] Start of interview [05:31] Challenges in nutrition and exercise recommendations [11:01] Behavior change in real-world practice [16:32] Self-monitoring and its importance [23:48] Non-scale victories and positive body image [25:58] Focusing on body capabilities over aesthetics [27:20] Integrating activity into lifestyle [30:30] Exercise snacking and practical tips [33:36] Impact of GLP-1 receptor agonists [38:24] Addressing fear of weight regain [41:24] Effective multidisciplinary obesity treatment Related Resources Go to episode page Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course LinkedIn: Dr. David Creel Danny Lennon X/Twitter: @drdavidcreel @NutritionDanny

Omega-3 fatty acids (particularly EPA and DHA) have a long history in nutrition and cardiovascular medicine, yet the clinical trial literature is often perceived as inconsistent. This episode examines why some randomized trials show clear benefit while others show null or mixed findings, and how differences in trial design, dose, population risk, and outcome selection can materially change what we observe. A key theme is separating (1) the persistent cultural narratives around omega-3s (including origin stories that do not hold up well to modern evidence) from (2) the more precise, mechanistic and clinical questions about where supplemental EPA/DHA may reduce cardiovascular risk. The discussion focuses heavily on understanding heterogeneity: why "omega-3 supplementation" is not a single, uniform exposure, and why subgroup patterns (e.g., secondary prevention, higher baseline triglycerides, and higher doses) may explain much of the apparent conflict in the evidence. Note: This discussion is taken from a previous episode of the podcast. The audio has been remastered and improved, and now study notes and full transcript are available. Timestamps [04:10] Omega-3 historical context and Inuit studies [08:38] Mechanisms of omega-3 benefits [12:49] VITAL and ASCEND trials analysis [23:41] GISSI-Prevenzione trial insights [26:44] REDUCE-IT trial and residual risk [32:19] Significance of baseline triglycerides [37:57] 2018 Cochrane review [46:02] Hu et al. meta-analysis [01:00:27] Practical takeaways for omega-3 supplementation [01:03:55] Key ideas segment (premium subscribers only) Related Resources Go to episode page (with links to mentioned studies) Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Alan Flanagan's Alinea Nutrition Education Hub

Conversations about brain health have been dominated by a competing mix of fatalism and over-promising, with aging framed as inevitable decline and "brain optimisation" sold through weak evidence. So how should we think about cognition across the lifespan? In this episode, we explore the idea that neuroplasticity does not disappear in adulthood, but instead continues to respond, for better or worse, to repeated behaviours and exposures. Much of what is labelled age-related cognitive decline may in fact reflect an accumulation of modifiable risk factors. We also dig into how to critically evaluate brain-health claims and how lifestyle pillars such as exercise, sleep, diet, stress reduction and cognitive training fit into a coherent framework. The discussion extends to emerging multimodal intervention programs, their promising signals and their clear limitations, and to a broader, multifactorial view of Alzheimer's disease that moves beyond a narrow amyloid-centric model. Finally, we examine the role of genetics, including ApoE4, and why genetic risk does not equate to biological destiny, even later in life. Dr. Majid Fotuhi is a neurologist and an adjunct professor at the Johns Hopkins Mind/Brain Institute. He earned his medical degree from Harvard Medical School and completed a Ph.D. in neuroscience at Johns Hopkins University. That was followed by internship and neurology residency at Johns Hopkins Hospital. Timestamps [03:41] Understanding neuroplasticity [05:22] Risk factors for cognitive decline [07:07] Evidence-based interventions for brain health [09:37] The five pillars of brain health [10:42] Dr. Fotuhi's multimodal program [19:09] Measuring cognitive function [24:43] The role of amyloid and tau in Alzheimer's [27:53] Genetics and lifestyle in brain health [30:03] Debunking myths and overhyped claims [36:08] Key ideas segment (premium subscribers only) Related Resources Go to episode page (with links to studies mentioned) Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Dr. Fotuhi's book: The Invincible Brain

This is a Premium-exclusive episode of the podcast. To listen to the full episode you need to be subscribed to Sigma Nutrition Premium. This episode examines dietary fiber through the lens of a practical, clinically relevant question: if higher fiber intakes are consistently associated with reduced chronic disease risk, what intake level should we be aiming for to meaningfully improve health outcomes? The discussion deliberately spans from common online claims that fiber is "not essential" (and therefore unnecessary), through to mechanistic reasoning and the highest-quality evidence we have for hard outcomes and accepted intermediate cardiometabolic endpoints. Across the episode, we'll hear from six expert perspectives to integrate epidemiology, controlled feeding studies, and clinical guideline contexts. We will consider how the dose–response patterns, fiber type/source, individual tolerance, and the limitations of nutrition trials all influence what can be recommended with confidence. Timestamps [03:51] Addressing the claim "fiber is not an essential nutrient" [11:23] Carbohydrate quality and fiber [17:16] Dietary recommendations for fiber [20:01] Portfolio diet and cardiovascular health [26:48] Comparing fiber sources [36:07] Epidemiological evidence on fiber [41:57] Understanding fiber intake and coronary heart disease [43:23] Fiber intake and colorectal cancer [54:06] Diet swap study: south african vs. african american diets [01:01:47] High fiber diets and diabetes [01:16:18] Challenges in fiber intake and IBS [01:21:45] Concluding thoughts on fiber intake Related Resources Subscribe to Sigma Nutrition Premium Go to episode page (with links to mentioned studies) Join the Sigma email newsletter for free Enroll in the next cohort of our Applied Nutrition Literacy course

Dr. José Areta and colleagues recently carried out a human intervention study examining how a pronounced, short-term energy deficit interacts with an aerobic training stimulus to shape endocrine, metabolic, and skeletal muscle proteomic adaptations. The core premise is that "low energy availability" is often discussed in a largely unidirectional risk framework, yet human physiology evolved under intermittent energy scarcity, and therefore adaptive responses may be more nuanced than "energy deficit equals impaired adaptation." The study used tightly controlled diet and exercise, repeated muscle biopsies, and dynamic proteomic profiling to quantify both abundance and synthesis rates of hundreds of individual muscle proteins. This enables a more granular view of "muscle quality" and phenotype than traditional bulk muscle protein synthesis measures. The findings were incredibly interesting and could have implications for how we view the impact of energy deficits and exercise response. We discuss the implications for athletes who routinely encounter transient within-day or multi-day energy deficits, for weight loss contexts, and for broader questions around healthspan and ageing biology. Timestamps [02:27] Guest introduction [03:28] Research background and study design [12:18] Study findings: weight loss and endocrine responses [15:47] Muscle adaptations and proteomic analysis [21:47] Interpreting the results: evolutionary and practical implications [26:57] Mitochondrial proteins and muscle adaptation [28:44] Energy deficit as a stressor [34:26] Case study: female tour de france athlete [40:20] Implications for clinical populations [41:44] Future research directions [46:48] Key ideas segment (Premium subcribers only) Related Resources Go to episode page (with links to studies) Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course X: @jlareta

While the term "hyperpalatable" has been used frequently for considerable time to refer to foods that are so appealing and tasty that they drive overeating, this term hasn't been well-defined nor has there been a universal standard for what it means. One researcher who set out to create an objective definition for hyper-palatable foods (HPFs) is Dr. Tera Fazzino. Using specific defined thresholds of sugar, fat and salt combinations, Dr. Fazzino and colleagues have looked at the impact of consumption of these HPFs. In this episode, we delve into defining HPFs and their nutrient profiles, whether they have addictive-like properties, how HPFs differ from (and overlap with) ultra-processed foods (UPFs), the mechanisms by which these foods drive overconsumption, and the broader public health implications. Tera Fazzino, PhD, is an associate professor of psychology at the University of Kansas. Her research focuses on addiction, obesity, and eating-related behaviors. Timestamps [03:39] Interview begins [05:05] Attempting to define hyper palatability [10:03] Nutrient combinations in hyper palatable foods [14:54] Prevalence of hyper palatable foods [17:43] Debate on ultra processed foods [30:02] Mechanisms behind hyper palatability [35:06] Addiction theory and hyper-palatable foods [43:38] Early exposure and long-term effects [50:53] Key ideas recap Related Resources Go to episode page (with links to studies mentioned) Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course

In this episode, the discussion turns to a deceptively simple question that sits at the centre of countless nutrition debates: how much protein do we actually need? On one side, there are confident claims that very high protein intakes are not just beneficial but essential for maximising strength, performance, and muscle mass. On the other, equally strong assertions that the current RDA is entirely sufficient for most people, and that going beyond it is unnecessary or even harmful. Dr. Eric Helms and Dr. Matthew Nagra work through what the evidence actually tells us when we step away from slogans and thresholds. What does 0.8 g/kg represent, and just as importantly, what does it not? At what point do higher intakes stop meaningfully improving muscle-related outcomes? And where do concerns about kidney function, longevity, and chronic disease fit when we look at long-term data rather than isolated mechanisms? Rather than treating protein as a single number to defend or dismiss, this conversation places intake in context: training status, ageing, health outcomes, source and optimising for specific goals. Timestamps [05:19] Discussion starts [07:18] Setting the scene: protein intake and health [09:38] Health outcomes and protein intake [10:27] Mechanistic measures vs. longitudinal outcomes [15:47] The RDA: purpose and limitations [19:19] Higher protein recommendations: where do they come from? [21:48] Protein intake for athletes and general population [27:25] Dose response and optimal protein intake [44:59] Statistical errors in Morton meta-analysis [46:07] Comparing meta-analyses: Morton, Tagawa, and Nunez [56:23] Mechanistic claims and protein intake [59:49] Nitrogen balance and protein requirements [01:11:55] Protein sources and health outcomes [01:18:13] Summarizing optimal protein intake [01:24:31] Key ideas segment (premium subscribers only) Related Resources Go to the episode page (with linked studies & resources) Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Dr. Helms: MASS Research Review Muscle & Strength Pyramids books Instagram: @helms3dmj Dr. Nagra: Instagram: @dr.matthewnagra Dr. Nagra's website

Maintaining the ability to carry out everyday tasks and live independently is often described as a cornerstone of healthy ageing. But what actually happens to muscle strength, power, and functional ability as we get older? And how inevitable is their decline? At what point do changes in muscle function really begin to matter for day-to-day life? Is loss of strength an unavoidable consequence of ageing itself, or does it reflect something more modifiable? If declines are not fixed, what kinds of training or lifestyle interventions genuinely make a difference, and how strong is the evidence behind them? In this episode, exercise physiologist Dr Brendan Egan examines these questions through the lens of both epidemiological data and controlled training studies in older adults. What do we learn from short-term resistance training interventions lasting just a few months? Do the gains persist once supervised training ends? And what does this tell us about the practical challenges of maintaining functional capacity over the long term? The conversation also explores the idea of "use it or lose it" in muscle function, the role of resistance training in extending healthspan, and how exercise programmes can be designed to support independence later in life. Ultimately, the episode asks a simple but crucial question: what does the evidence actually say about staying strong, capable, and functionally independent as we age? Dr. Brendan Egan is an Associate Professor of Sport and Exercise Physiology the School of Health and Human Performance at Dublin City University. Currently, he is Associate Dean for Research in the Faculty of Science and Health. Timestamps [03:49] Understanding functional capacity [05:56] The importance of muscle strength and mass [14:09] Epidemiology and strength training [25:07] Concurrent training in older adults study [31:05] Barriers to strength training in older adults [34:18] Misconceptions about older adults and exercise [39:13] Exercise snacking and SBAE [51:04] Key ideas segment (Premium-only) Links & Resources Go to episode page (with links to studies) Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course

Nutrient density refers to the concentration of vitamins and minerals in crops relative to their yield. There are widespread claims that today's fruits, vegetables, and grains contain fewer micronutrients than in decades past, often linked to modern farming practices or soil degradation. This issue is important because if staple crops become less nutritious, it could silently undermine dietary quality and contribute to micronutrient deficiencies ("hidden hunger") in populations. Dr. Edward Joy is uniquely qualified to address this topic. As a senior research fellow in food systems and nutrition at Rothamsted Research and an associate professor at the London School of Hygiene & Tropical Medicine, his work centers on the intersection of agriculture and nutrition. In this conversation, Dr. Joy draws on evidence from agronomy and public health to clarify whether the nutrient content of crops has indeed declined, what factors might be responsible (from soil health to plant breeding and climate change), and what we can do to improve the situation. The discussion emphasizes an evidence-based perspective on soil nutrients, crop varieties, and interventions, cutting through myths to identify real concerns and practical solutions. Timestamps [00:55] Interview [04:49] Understanding nutrient density and soil health [10:25] Historical evidence and crop experiments [20:39] Impact of climate change on crop nutrition [24:05] Potential solutions and future research [30:34] Translating research to human health Related Resources Go to episode page Join the Sigma email newsletter for free Subscribe to Sigma Nutrition Premium Enroll in the next cohort of our Applied Nutrition Literacy course Rothamsted Research Dr. Joy's profile page X/Twitter: @edward_joy1 @NutritionDanny

This is a Premium-exclusive episode of the podcast. To listen to the full episode you need to be subscribed to Sigma Nutrition Premium. Recently we (Danny Lennon & Alan Flanagan) were invited to 'Processing the Evidence', a "behind closed doors" workshop to discuss the latest scientific evidence on the role of processed foods in human health. The event was organized by Professors Ciarán Forde and Vincenzo Fogliano of Wageningen University in the Netherlands. The workshop attendees included a range of prominent researchers across a range of domains related to food processing, nutrition science, and public health. The sessions included open discussions on current evidence, knowledge gaps and challenges within the UPF debate. There were several structured sessions looking at different sub-topics, such as: Emulsifier-gut interactions Ultra-processing and its effect on food matrix and bioavailability Food liking and hedonic overeating UPFs: Interpreting nutritional epidemiology and RCTs New trial data: the PROMENADE trial, the RESTRUCTURE Trial, etc. In this episode, Alan and Danny review some of the key talking points and their takeaways from this event. Timestamps [00:31] Event overview: processing the evidence [04:44] Conference insights with Dr. Alan Flanagan [07:52] Hypotheses on ultra processed foods [11:53] Microbiome and additives panel [21:51] Food science and technology panel [33:21] Behavioral aspects of food consumption [38:10] Nutritional epidemiology session [47:19] Discussion on dietary pattern classification [50:19] The role of ultra-processed foods in public health policy [54:18] Clinical and metabolic data on processed foods [01:00:55] Critique of the NOVA classification system [01:08:03] Concluding thoughts on ultra-processed foods [01:23:12] Key ideas and methodological standpoints Related Resources Subscribe to Sigma Nutrition Premium Go to episode page Join the Sigma email newsletter for free Enroll in the next cohort of our Applied Nutrition Literacy course